Publication:
Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model

dc.contributor.authorTripanichkul W.
dc.contributor.authorJaroensuppaperch E.-O.
dc.date.accessioned2021-04-05T03:34:18Z
dc.date.available2021-04-05T03:34:18Z
dc.date.issued2012
dc.date.issuedBE2555
dc.description.abstractThis study investigated the effects of curcumin on nigrostriatal dopaminergic (DA) neurons and glial response in 6-hydroxydopamine (6-OHDA) hemiparkinsonian mice. Following unilateral intrastriatal 6-OHDA injection, mice were daily injected with curcumin for seven days, beginning on the day of lesion. Seven days after 6-OHDA lesioning, sections from the striatum and the substantia nigra pars compacta (SNpc) were collected and immunohistochemically stained for DA neurons and reactive glia. Curcumin decreased 6-OHDA-induced loss of nigral tyrosine hydroxylase-immunoreactive (TH-IR) neurons and striatal TH-IR fibers. The neuroprotection was coincided with a significant attenuation of microglial and astroglial reaction in the SNpc and the striatum. These results suggest that the neuroprotective effects of curcumin in 6-OHDA-lesioned mice may be mediated through its anti-inflammatory properties or direct protection on nigral DA neurons, thereby reducing neuronal injury-induced glial activation. © 2011 Informa Healthcare USA, Inc.
dc.format.mimetypeapplication/pdf
dc.identifier.citationInternational Journal of Neuroscience. Vol 122, No.5 (2012), p.263-270
dc.identifier.doi10.3109/00207454.2011.648760
dc.identifier.issn207454
dc.identifier.other2-s2.0-84859395842
dc.identifier.urihttps://swu-dspace2.eval.plus/handle/123456789/7067
dc.rights.holderScopus
dc.subject.otherCurcumin
dc.subject.otherOxidopamine
dc.subject.otherTyrosine 3 monooxygenase
dc.subject.otherAnimal experiment
dc.subject.otherAnimal model
dc.subject.otherAnimal tissue
dc.subject.otherArticle
dc.subject.otherControlled study
dc.subject.otherCorpus striatum
dc.subject.otherDopaminergic nerve cell
dc.subject.otherGlia
dc.subject.otherImmunohistochemistry
dc.subject.otherImmunoreactivity
dc.subject.otherMacroglia
dc.subject.otherMale
dc.subject.otherMouse
dc.subject.otherNeuroprotection
dc.subject.otherNigroneostriatal system
dc.subject.otherNonhuman
dc.subject.otherParkinsonism
dc.subject.otherSubstantia nigra
dc.subject.otherAnimals
dc.subject.otherCorpus Striatum
dc.subject.otherCurcumin
dc.subject.otherDisease Models, Animal
dc.subject.otherDopaminergic Neurons
dc.subject.otherMale
dc.subject.otherMice
dc.subject.otherMice, Inbred ICR
dc.subject.otherNeural Pathways
dc.subject.otherNeuroglia
dc.subject.otherParkinsonian Disorders
dc.subject.otherSubstantia Nigra
dc.subject.otherTreatment Outcome
dc.titleCurcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84859395842&doi=10.3109%2f00207454.2011.648760&partnerID=40&md5=b3358bf5ed86d31414dd84758be0e724

Files